Toronto - Delayed Quote CAD

Microbix Biosystems Inc. (MBX.TO)

0.3500
-0.0300
(-7.89%)
At close: May 8 at 3:38:49 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
23,030.2660
25,394.1480
16,514.7760
19,076.2410
18,592.9600
Cost of Revenue
10,108.2160
10,002.4470
9,033.4420
7,951.3990
7,549.0200
Gross Profit
12,922.0500
15,391.7010
7,481.3340
11,124.8420
11,043.9400
Operating Expense
10,616.8110
11,486.6890
10,217.7660
8,514.6290
6,207.3450
Operating Income
2,305.2390
3,905.0120
-2,736.4320
2,610.2130
4,836.5950
Net Non Operating Interest Income Expense
-232.9130
-234.2690
-381.6360
-744.2900
-1,603.2050
Other Income Expense
-3,078.5850
--
3,078.5850
--
--
Pretax Income
2,072.3250
3,670.7420
-39.4830
1,865.9230
3,233.3900
Tax Provision
1,568.2370
150.5630
0
77.2340
0
Net Income Common Stockholders
1,921.7620
3,520.1790
-39.4830
1,788.6890
3,233.3900
Diluted NI Available to Com Stockholders
1,921.7620
3,520.1790
-39.4830
1,788.6890
3,233.3900
Basic EPS
0.01
0.03
0.00
0.01
0.03
Diluted EPS
0.01
0.03
0.00
0.01
0.03
Basic Average Shares
136,282.8410
136,697.6600
137,911.8840
135,376.2550
114,845.4250
Diluted Average Shares
137,234.3550
137,490.8480
137,911.8840
141,688.2490
141,683.2090
Total Operating Income as Reported
--
3,905.0110
-2,736.4320
2,610.2130
--
Total Expenses
20,725.0270
21,489.1360
19,251.2080
16,466.0280
13,756.3650
Net Income from Continuing & Discontinued Operation
1,921.7620
3,520.1790
-39.4830
1,788.6890
3,233.3900
Normalized Income
1,921.7620
3,520.1790
-3,118.0680
1,788.6890
3,233.3900
Interest Income
690.8220
687.5060
457.7420
82.2700
0.0660
Interest Expense
923.7350
921.7750
839.3780
826.5600
1,603.2710
Net Interest Income
-232.9130
-234.2690
-381.6360
-744.2900
-1,603.2050
EBIT
2,996.0600
4,592.5170
799.8950
2,692.4830
4,836.6610
EBITDA
4,661.3840
6,205.3300
1,957.0640
3,728.8830
5,658.7010
Reconciled Cost of Revenue
10,108.2160
8,871.7720
8,037.5170
7,075.3430
6,826.3830
Reconciled Depreciation
1,665.3240
1,612.8130
1,157.1690
1,036.4000
822.0400
Net Income from Continuing Operation Net Minority Interest
1,921.7620
3,520.1790
-39.4830
1,788.6890
3,233.3900
Total Unusual Items Excluding Goodwill
0
0
3,078.5850
0
--
Total Unusual Items
0
0
3,078.5850
0
--
Normalized EBITDA
4,661.3840
6,205.3300
-1,121.5210
3,728.8830
5,658.7010
Tax Rate for Calcs
0.0002
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
9/30/2021 - 8/13/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MBX MBX Biosciences, Inc.
11.71
+8.13%
 
RVX.TO Resverlogix Corp.
0.0450
0.00%
 
APS.TO Aptose Biosciences Inc.
2.2200
+3.26%
 
COV.V Covalon Technologies Ltd.
2.5600
+2.40%
 
TELIF Telescope Innovations Corp.
0.1929
0.00%
 
BETR.CN BetterLife Pharma Inc.
0.0950
+5.56%
 
KNE.V Kane Biotech Inc.
0.0800
0.00%
 
068270.KS Celltrion, Inc.
158,000.00
-0.88%
 
MDNA.TO Medicenna Therapeutics Corp.
1.0000
+5.26%
 
APLI.TO Appili Therapeutics Inc.
0.0350
+16.67%